<DOC>
	<DOC>NCT01161654</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Naratriptan Hydrochloride Tablet under fed conditions.</brief_summary>
	<brief_title>Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Naratriptan</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to naratriptan hydrochloride or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>